As part of our commitment to deliver innovative therapies to patients across the globe, ResMed believes in the need to support ethical, independent clinical research, conducted by qualified third-party investigators. Investigator Initiated Trials (IITs) serve as an important complement to ResMed-sponsored research, to help better understand the benefits and risks of our therapies, as well as to explore new opportunities to address unmet medical needs. Such clinical research must be aimed at addressing meaningful scientific and/or clinical objectives, supported by valid study designs in which the safety, welfare and privacy rights of patients are of paramount importance.
Like many other
Grants will be considered to support independent medical research with scientific merit, provided that the following guidelines are met:
• The research proposal addresses a legitimate scientific need that is identified and documented in advance (ResMed does not consider requests for unrestricted grants).
• The principal investigator must have the appropriate education,
• If a research proposal is accepted, a written agreement with well-defined goals,
Checklist for Proposal Submission
A concept proposal should contain an adequate amount of information in order for ResMed to determine interest in receiving a full submission. You may also consider submitting a full submission alone.
The full submission checklist is provided to ensure that proposals contain all the necessary documentation required for evaluation. A full proposal submission must contain enough detail about the research study and the grant request to enable ResMed to make a final evaluation regarding support.
You can find additional details on ResMed’s support for Investigator Initiated Trials here.
Need more information?
For further information about research grants, please contact the Office of Medical Affairs at MedicalAffairs-IIT@resmed.com